Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply

By afschroeder • May 14, 2026

Rana AI, Castillo-Mancilla J, Landovitz RJ. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply. N Engl J Med. 2026 May 14;394(19):1963-1964. doi: 10.1056/NEJMc2604136. PMID: 42127403.

Tags: Infectious Diseases, Publications

Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial

Vyshenska D, Reed JC, Roychoudhury P, Zheng L, Olefsky M, Ritz J, McCarthy C, Saha PT, Hao L, Mills MG, Shea A, Nunley BE, Javan[...]

Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group

Osakwe CE, Schaefer R, Donaldson L, Abiodun AS, Chatani-Gada M, Chigome AK, Day S, Deaton C, Elemuwa UG, Ingold H, Joseph Davey D, Kersey K,[...]

A Community-Based Intervention to Increase PrEP Initiation and Reduce Internalized Stigma: A Randomized Trial Among Black Sexual Minority Men in Prince George’s County, Maryland

Turpin RE, Wilson GT, Davidson Mhonde RR, Camp AD, Dyer TV, Mayer KH, Liu H, Coates T, Boekeloo B. A Community-Based Intervention to Increase PrEP[...]